目的探討肝細(xì)胞膽管膜上轉(zhuǎn)運(yùn)子BSEP、MRP2和MDR3與膽囊膽固醇結(jié)石形成的關(guān)系。
方法收集膽囊膽固醇結(jié)石患者的肝組織標(biāo)本20例,正常肝組織標(biāo)本10例。應(yīng)用逆轉(zhuǎn)錄聚合酶鏈反應(yīng)(RTPCR)技術(shù)和Western blot技術(shù)檢測(cè)BSEP、MRP2及MDR3 mRNA和蛋白的表達(dá)。
結(jié)果膽囊膽固醇結(jié)石患者肝組織中BSEP、MRP2和MDR3 的mRNA及蛋白表達(dá)均顯著低于正常肝組織(P<0.01)。
結(jié)論 BSEP、MRP2和MDR3的表達(dá)降低可能與膽囊膽固醇結(jié)石的形成有關(guān)。
引用本文: 孔凡民,隋春陽,李航宇,李昱驥,孫宏治,郭仁宣,郭克建,田雨霖. 膽囊膽固醇結(jié)石與肝細(xì)胞膽管膜上轉(zhuǎn)運(yùn)子BSEP、MRP2和MDR3關(guān)系的研究. 中國(guó)普外基礎(chǔ)與臨床雜志, 2006, 13(3): 314-316. doi: 復(fù)制
1. | [J]. Scand J Gastroenterol, 2004; 241(Suppl)∶ 60. |
2. | van BergeHenegouwen GP, Venneman NG, Portincasa P, et al. Relevance of hereditary defects in lipid transport proteins for the pathogenesis of cholesterol gallstone disease. |
3. | Trauner M, Boyer JL. Bile salt transporters: molecular characterization, function, and regulation [J]. Physiol Rev, 2003; 83(2)∶633. |
4. | Hoda F, Green RM. Hepatic canalicular membrane transport of bile salt in C57L/J and AKR/J mice: implications for cholesterol gallstone formation [J]. J Membr Biol, 2003; 196(1)∶9. |
5. | Huang L, Zhao A, Lew JL, et al. Farnesoid X receptor activates transcription of the phospholipid pump MDR3 [J]. J Biol Chem, 2003; 278(51)∶51085. |
6. | Meier PJ, Stieger B. Bile salt transporters [J]. Annu Rev Physiol, 2002; 64(2)∶635. |
7. | Plass JR, Mol O, Heegsma J, et al. A progressive familial intrahepatic cholestasis type 2 mutation causes an unstable, temperaturesensitive bile salt export pump [J]. J Hepatol, 2004; 40(1)∶24. |
8. | Fickert P, Fuchsbichler A, Wagner M, et al. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice [J]. Gastroenterology, 2004; 127(1)∶261. |
9. | Shoda J, Oda K, Suzuki H, et al. Etiologic significance of defects in cholesterol, phospholipid, and bile acid metabolism in the liver of patients with intrahepatic calculi [J]. Hepatology, 2001; 33(5)∶1194. |
10. | Smit JJ, Schinkel AH, Oude Elferink RP, et al. Homozygous disruption of the murine mdr2 Pglycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease [J]. Cell, 1993; 75(3)∶451. |
11. | 劉君, 龍厚勇, 明晗昕, 等. 肝細(xì)胞MDR1基因表達(dá)與膽囊膽固醇結(jié)石相關(guān)性研究 [J]. 中國(guó)普外基礎(chǔ)與臨床雜志, 2005; 12(4)∶346. |
- 1. [J]. Scand J Gastroenterol, 2004; 241(Suppl)∶ 60.
- 2. van BergeHenegouwen GP, Venneman NG, Portincasa P, et al. Relevance of hereditary defects in lipid transport proteins for the pathogenesis of cholesterol gallstone disease.
- 3. Trauner M, Boyer JL. Bile salt transporters: molecular characterization, function, and regulation [J]. Physiol Rev, 2003; 83(2)∶633.
- 4. Hoda F, Green RM. Hepatic canalicular membrane transport of bile salt in C57L/J and AKR/J mice: implications for cholesterol gallstone formation [J]. J Membr Biol, 2003; 196(1)∶9.
- 5. Huang L, Zhao A, Lew JL, et al. Farnesoid X receptor activates transcription of the phospholipid pump MDR3 [J]. J Biol Chem, 2003; 278(51)∶51085.
- 6. Meier PJ, Stieger B. Bile salt transporters [J]. Annu Rev Physiol, 2002; 64(2)∶635.
- 7. Plass JR, Mol O, Heegsma J, et al. A progressive familial intrahepatic cholestasis type 2 mutation causes an unstable, temperaturesensitive bile salt export pump [J]. J Hepatol, 2004; 40(1)∶24.
- 8. Fickert P, Fuchsbichler A, Wagner M, et al. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice [J]. Gastroenterology, 2004; 127(1)∶261.
- 9. Shoda J, Oda K, Suzuki H, et al. Etiologic significance of defects in cholesterol, phospholipid, and bile acid metabolism in the liver of patients with intrahepatic calculi [J]. Hepatology, 2001; 33(5)∶1194.
- 10. Smit JJ, Schinkel AH, Oude Elferink RP, et al. Homozygous disruption of the murine mdr2 Pglycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease [J]. Cell, 1993; 75(3)∶451.
- 11. 劉君, 龍厚勇, 明晗昕, 等. 肝細(xì)胞MDR1基因表達(dá)與膽囊膽固醇結(jié)石相關(guān)性研究 [J]. 中國(guó)普外基礎(chǔ)與臨床雜志, 2005; 12(4)∶346.